PharmaCorp Rx (TSXV:PCRX) Total Assets: C$63.13 Mil (As of Mar. 2026)


TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
35 GF Score
Price C$0.58
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Total Assets?

PharmaCorp Rx TSXV:PCRX +16.00% 35 Total Assets is C$63.13 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 35/100. The stock has 2 warning signs investors should review.

PharmaCorp Rx's Total Assets for the quarter that ended in Mar. 2026 was C$63.13 Mil.

During the past 12 months, PharmaCorp Rx's average Total Assets Growth Rate was 76.70% per year.

During the past 5 years, PharmaCorp Rx's highest 3-Year average Total Assets Growth Rate was 920.60%. The lowest was 920.60%. And the median was 920.60%.

Total Assets is connected with ROA %. PharmaCorp Rx's annualized ROA % for the quarter that ended in Mar. 2026 was 0.67%. Total Assets is also linked to Revenue through Asset Turnover. PharmaCorp Rx's Asset Turnover for the quarter that ended in Mar. 2026 was 0.11.

PharmaCorp Rx  (TSXV:PCRX) Total Assets Explanation

Total Assets is connected with ROA %.

PharmaCorp Rx's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0.432/( (65.57+63.132)/ 2 )
=0.432/64.351
=0.67 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

PharmaCorp Rx's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=7.188/( (65.57+63.132)/ 2 )
=7.188/64.351
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

PharmaCorp Rx Total Assets Related Terms

PharmaCorp Rx Total Assets Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Total Assets Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
1.00 2.73 2.32 35.21 65.57

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 35.44 35.37 39.71 65.57 63.13
TSXV:PCRX
35GF Score
PharmaCorp Rx Inc TSXV:PCRX
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

PharmaCorp Rx's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=52.27+13.3
=65.57

PharmaCorp Rx's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=52.827+10.306
=63.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of C$63.13 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Total Assets of C$63.13 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Total Assets too high?
PharmaCorp Rx's current Total Assets is C$63.13 Mil. Overall, PharmaCorp Rx has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Total Assets compare to competitors?
PharmaCorp Rx's Total Assets of C$63.13 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Healthcare Providers & Services company?
A good Total Assets depends on the Healthcare Providers & Services industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Total Assets is C$63.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Total Assets of C$63.13 Mil. The current Total Assets is C$63.13 Mil. PharmaCorp Rx's overall GF Score™ is 35/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Total Assets is C$63.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
35GF Score

Get the complete analysis for TSXV:PCRX

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.58
Price